Published May 24, 2011 | Version v1
Journal article

Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy

  • 1. St James's Institute of Oncology, Leeds (United Kingdom)
  • 2. Istanbul University, Cerrahpasa Medical Faculty, Department of Biostatistic, Istanbul (Turkey)
  • 3. Christie Hospital, Manchester (United Kingdom)

Description

To establish recurrence patterns among locally advanced head and neck non-nasopharyngeal squamous cell carcinoma (HNSCC) patients treated with radical (chemo-) radiotherapy and to correlate the sites of loco-regional recurrence with radiotherapy doses and target volumes 151 locally advanced HNSCC patients were treated between 2004-2005 using radical three-dimensional conformal radiotherapy. Patients with prior surgery to the primary tumour site were excluded. The sites of locoregional relapses were correlated with radiotherapy plans by the radiologist and a planning dosimetrist. Median age was 59 years (range:34-89). 35 patients had stage III disease, 116 patients had stage IV A/B. 36 patients were treated with radiotherapy alone, 42 with induction chemotherapy, 63 with induction and concomitant chemoradiotherapy and 10 concomitant chemoradiotherapy. Median follow-up was 38 months (range 3-62). 3-year cause specific survival was 66.8%. 125 of 151 (82.8%) achieved a complete response to treatment. Amongst these 125 there were 20 local-regional recurrence, comprising 8 local, 5 regional and 7 simultaneous local and regional; synchronous distant metastases occurred in 7 of the 20. 9 patients developed distant metastases in the absence of locoregional failure. For the 14 local recurrences with planning data available, 12 were in-field, 1 was marginal, and 1 was out-of-field. Of the 11 regional failures with planning data available, 7 were in-field, 1 was marginal and 3 were out-of-field recurrences. The majority of failures following non-surgical treatment for locally advanced HNSCC were loco-regional, within the radiotherapy target volume. Improving locoregional control remains a high priority

Availability note (English)

Available from http://dx.doi.org/10.1186/1748-717X-6-54; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127781

Additional details

Publishing Information

Journal Title
Radiation Oncology (Online)
Journal Volume
6
Journal Page Range
p. 54
ISSN
1748-717X

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47061699
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CARCINOMAS; COMBINED THERAPY; FAILURES; HEAD; NECK; PATIENTS; RADIOTHERAPY
Descriptors DEC
BODY; DISEASES; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c)2011 Oksuz et al
Notes
PMCID: PMC3127781; PUBLISHER-ID: 1748-717X-6-54; PMID: 21609453; OAI: oai:pubmedcentral.nih.gov:3127781; licensee BioMed Central Ltd.